{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.5047","meta":{"versionId":"14","lastUpdated":"2022-07-15T01:02:56.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Clinical Architecture"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-07-15"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5047","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.3616.200.110.102.5047"}],"version":"20220715","name":"SARSCoronavirus2IgMQualitativeAndQuantitative","title":"SARS Coronavirus 2 IgM, Qualitative and Quantitative","status":"retired","experimental":false,"date":"2023-06-21T18:16:37-04:00","publisher":"Clinical Architecture","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains terms related to qualitative and quantitative detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2) in serum or plasma.),(Data Element Scope: ),(Inclusion Criteria: Includes detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2) in serum or plasma.),(Exclusion Criteria: )","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"94506-3","display":"SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"code":"94508-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay"},{"code":"94564-2","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay"},{"code":"95416-4","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay"},{"code":"95428-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence"}]}]},"expansion":{"identifier":"urn:uuid:451ba11c-35e8-415e-be0a-f4e2595ce616","timestamp":"2023-12-11T01:42:33-05:00","total":5,"contains":[{"system":"http://loinc.org","version":"2.76","code":"94506-3","display":"SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.76","code":"94508-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay"},{"system":"http://loinc.org","version":"2.76","code":"94564-2","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay"},{"system":"http://loinc.org","version":"2.76","code":"95416-4","display":"SARS-CoV-2 (COVID-19) IgM Ab [Presence] in DBS by Immunoassay"},{"system":"http://loinc.org","version":"2.76","code":"95428-9","display":"SARS-CoV-2 (COVID-19) IgM Ab [Titer] in Serum or Plasma by Immunofluorescence"}]}}